世界の犬乳腺腫瘍治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Canine Mammary Tumor Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3963 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、犬乳腺腫瘍治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（腺腫、癌腫、腺癌）、用途別市場規模（獣医病院、獣医クリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・犬乳腺腫瘍治療の市場動向 ・企業の競争状況、市場シェア ・犬乳腺腫瘍治療の種類別市場規模と予測2016-2027（腺腫、癌腫、腺癌） ・犬乳腺腫瘍治療の用途別市場規模と予測2016-2027（獣医病院、獣医クリニック、その他） ・犬乳腺腫瘍治療の北米市場規模2016-2027（アメリカ、カナダ） ・犬乳腺腫瘍治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・犬乳腺腫瘍治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・犬乳腺腫瘍治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・犬乳腺腫瘍治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Oasmia Pharmaceuticals AB、Aratana Therapeutics, Inc.、VetDC, Inc.、AB Science、Boehringer Ingelheim International GmbH、Zoetis、VCA Hospitals、Karyopharm Therapeutics, Inc.、Rhizen Pharmaceuticals SA） ・結論

Mammary Tumor is a tumor of the mammary tissue and is most common in unspayed dogs, and in dogs spayed after their first heat cycle. Dogs have five pairs of mammary glands with glands near the armpit region and in the glands located in inguinal area. The mammary tumor is frequently found in toy, miniature, spaniels, and German shepherd breeds. Male dogs are rarely impacted by this kind of tumor. Mammary tumors are found in various sizes and shapes, and can move to underlying tissue. Many dogs develop single tumor in one gland and others develop multiple tumors within same gland.

Market Analysis and Insights: Global Canine Mammary Tumor Treatment Market
The global Canine Mammary Tumor Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Canine Mammary Tumor Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Canine Mammary Tumor Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Canine Mammary Tumor Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Canine Mammary Tumor Treatment market.

Global Canine Mammary Tumor Treatment Scope and Market Size
Canine Mammary Tumor Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Canine Mammary Tumor Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
By Type
Adenomas
Carcinomas
Adenocarcinomas
By Treatment
Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
Chemotherapy
Radiation Therapy
Surgery
Prognosis

Segment by Application
Veterinary Hospitals
Veterinary Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Oasmia Pharmaceuticals AB
Aratana Therapeutics, Inc.
VetDC, Inc.
AB Science
Boehringer Ingelheim International GmbH
Zoetis
VCA Hospitals
Karyopharm Therapeutics, Inc.
Rhizen Pharmaceuticals SA

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Canine Mammary Tumor Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Adenomas
1.2.3 Carcinomas
1.2.4 Adenocarcinomas
1.3 Market by Application
1.3.1 Global Canine Mammary Tumor Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Veterinary Hospitals
1.3.3 Veterinary Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Canine Mammary Tumor Treatment Market Perspective (2016-2027)
2.2 Canine Mammary Tumor Treatment Growth Trends by Regions
2.2.1 Canine Mammary Tumor Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Canine Mammary Tumor Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Canine Mammary Tumor Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Canine Mammary Tumor Treatment Industry Dynamic
2.3.1 Canine Mammary Tumor Treatment Market Trends
2.3.2 Canine Mammary Tumor Treatment Market Drivers
2.3.3 Canine Mammary Tumor Treatment Market Challenges
2.3.4 Canine Mammary Tumor Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Canine Mammary Tumor Treatment Players by Revenue
3.1.1 Global Top Canine Mammary Tumor Treatment Players by Revenue (2016-2021)
3.1.2 Global Canine Mammary Tumor Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Canine Mammary Tumor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Canine Mammary Tumor Treatment Revenue
3.4 Global Canine Mammary Tumor Treatment Market Concentration Ratio
3.4.1 Global Canine Mammary Tumor Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Canine Mammary Tumor Treatment Revenue in 2020
3.5 Canine Mammary Tumor Treatment Key Players Head office and Area Served
3.6 Key Players Canine Mammary Tumor Treatment Product Solution and Service
3.7 Date of Enter into Canine Mammary Tumor Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Canine Mammary Tumor Treatment Breakdown Data by Type
4.1 Global Canine Mammary Tumor Treatment Historic Market Size by Type (2016-2021)
4.2 Global Canine Mammary Tumor Treatment Forecasted Market Size by Type (2022-2027)

5 Canine Mammary Tumor Treatment Breakdown Data by Application
5.1 Global Canine Mammary Tumor Treatment Historic Market Size by Application (2016-2021)
5.2 Global Canine Mammary Tumor Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Canine Mammary Tumor Treatment Market Size (2016-2027)
6.2 North America Canine Mammary Tumor Treatment Market Size by Type
6.2.1 North America Canine Mammary Tumor Treatment Market Size by Type (2016-2021)
6.2.2 North America Canine Mammary Tumor Treatment Market Size by Type (2022-2027)
6.2.3 North America Canine Mammary Tumor Treatment Market Size by Type (2016-2027)
6.3 North America Canine Mammary Tumor Treatment Market Size by Application
6.3.1 North America Canine Mammary Tumor Treatment Market Size by Application (2016-2021)
6.3.2 North America Canine Mammary Tumor Treatment Market Size by Application (2022-2027)
6.3.3 North America Canine Mammary Tumor Treatment Market Size by Application (2016-2027)
6.4 North America Canine Mammary Tumor Treatment Market Size by Country
6.4.1 North America Canine Mammary Tumor Treatment Market Size by Country (2016-2021)
6.4.2 North America Canine Mammary Tumor Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Canine Mammary Tumor Treatment Market Size (2016-2027)
7.2 Europe Canine Mammary Tumor Treatment Market Size by Type
7.2.1 Europe Canine Mammary Tumor Treatment Market Size by Type (2016-2021)
7.2.2 Europe Canine Mammary Tumor Treatment Market Size by Type (2022-2027)
7.2.3 Europe Canine Mammary Tumor Treatment Market Size by Type (2016-2027)
7.3 Europe Canine Mammary Tumor Treatment Market Size by Application
7.3.1 Europe Canine Mammary Tumor Treatment Market Size by Application (2016-2021)
7.3.2 Europe Canine Mammary Tumor Treatment Market Size by Application (2022-2027)
7.3.3 Europe Canine Mammary Tumor Treatment Market Size by Application (2016-2027)
7.4 Europe Canine Mammary Tumor Treatment Market Size by Country
7.4.1 Europe Canine Mammary Tumor Treatment Market Size by Country (2016-2021)
7.4.2 Europe Canine Mammary Tumor Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Canine Mammary Tumor Treatment Market Size (2016-2027)
8.2 Asia-Pacific Canine Mammary Tumor Treatment Market Size by Type
8.2.1 Asia-Pacific Canine Mammary Tumor Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Canine Mammary Tumor Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Canine Mammary Tumor Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Canine Mammary Tumor Treatment Market Size by Application
8.3.1 Asia-Pacific Canine Mammary Tumor Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Canine Mammary Tumor Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Canine Mammary Tumor Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Canine Mammary Tumor Treatment Market Size by Region
8.4.1 Asia-Pacific Canine Mammary Tumor Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Canine Mammary Tumor Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Canine Mammary Tumor Treatment Market Size (2016-2027)
9.2 Latin America Canine Mammary Tumor Treatment Market Size by Type
9.2.1 Latin America Canine Mammary Tumor Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Canine Mammary Tumor Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Canine Mammary Tumor Treatment Market Size by Type (2016-2027)
9.3 Latin America Canine Mammary Tumor Treatment Market Size by Application
9.3.1 Latin America Canine Mammary Tumor Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Canine Mammary Tumor Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Canine Mammary Tumor Treatment Market Size by Application (2016-2027)
9.4 Latin America Canine Mammary Tumor Treatment Market Size by Country
9.4.1 Latin America Canine Mammary Tumor Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Canine Mammary Tumor Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Canine Mammary Tumor Treatment Market Size (2016-2027)
10.2 Middle East & Africa Canine Mammary Tumor Treatment Market Size by Type
10.2.1 Middle East & Africa Canine Mammary Tumor Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Canine Mammary Tumor Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Canine Mammary Tumor Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Canine Mammary Tumor Treatment Market Size by Application
10.3.1 Middle East & Africa Canine Mammary Tumor Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Canine Mammary Tumor Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Canine Mammary Tumor Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Canine Mammary Tumor Treatment Market Size by Country
10.4.1 Middle East & Africa Canine Mammary Tumor Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Canine Mammary Tumor Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Oasmia Pharmaceuticals AB
11.1.1 Oasmia Pharmaceuticals AB Company Details
11.1.2 Oasmia Pharmaceuticals AB Business Overview
11.1.3 Oasmia Pharmaceuticals AB Canine Mammary Tumor Treatment Introduction
11.1.4 Oasmia Pharmaceuticals AB Revenue in Canine Mammary Tumor Treatment Business (2016-2021)
11.1.5 Oasmia Pharmaceuticals AB Recent Development
11.2 Aratana Therapeutics, Inc.
11.2.1 Aratana Therapeutics, Inc. Company Details
11.2.2 Aratana Therapeutics, Inc. Business Overview
11.2.3 Aratana Therapeutics, Inc. Canine Mammary Tumor Treatment Introduction
11.2.4 Aratana Therapeutics, Inc. Revenue in Canine Mammary Tumor Treatment Business (2016-2021)
11.2.5 Aratana Therapeutics, Inc. Recent Development
11.3 VetDC, Inc.
11.3.1 VetDC, Inc. Company Details
11.3.2 VetDC, Inc. Business Overview
11.3.3 VetDC, Inc. Canine Mammary Tumor Treatment Introduction
11.3.4 VetDC, Inc. Revenue in Canine Mammary Tumor Treatment Business (2016-2021)
11.3.5 VetDC, Inc. Recent Development
11.4 AB Science
11.4.1 AB Science Company Details
11.4.2 AB Science Business Overview
11.4.3 AB Science Canine Mammary Tumor Treatment Introduction
11.4.4 AB Science Revenue in Canine Mammary Tumor Treatment Business (2016-2021)
11.4.5 AB Science Recent Development
11.5 Boehringer Ingelheim International GmbH
11.5.1 Boehringer Ingelheim International GmbH Company Details
11.5.2 Boehringer Ingelheim International GmbH Business Overview
11.5.3 Boehringer Ingelheim International GmbH Canine Mammary Tumor Treatment Introduction
11.5.4 Boehringer Ingelheim International GmbH Revenue in Canine Mammary Tumor Treatment Business (2016-2021)
11.5.5 Boehringer Ingelheim International GmbH Recent Development
11.6 Zoetis
11.6.1 Zoetis Company Details
11.6.2 Zoetis Business Overview
11.6.3 Zoetis Canine Mammary Tumor Treatment Introduction
11.6.4 Zoetis Revenue in Canine Mammary Tumor Treatment Business (2016-2021)
11.6.5 Zoetis Recent Development
11.7 VCA Hospitals
11.7.1 VCA Hospitals Company Details
11.7.2 VCA Hospitals Business Overview
11.7.3 VCA Hospitals Canine Mammary Tumor Treatment Introduction
11.7.4 VCA Hospitals Revenue in Canine Mammary Tumor Treatment Business (2016-2021)
11.7.5 VCA Hospitals Recent Development
11.8 Karyopharm Therapeutics, Inc.
11.8.1 Karyopharm Therapeutics, Inc. Company Details
11.8.2 Karyopharm Therapeutics, Inc. Business Overview
11.8.3 Karyopharm Therapeutics, Inc. Canine Mammary Tumor Treatment Introduction
11.8.4 Karyopharm Therapeutics, Inc. Revenue in Canine Mammary Tumor Treatment Business (2016-2021)
11.8.5 Karyopharm Therapeutics, Inc. Recent Development
11.9 Rhizen Pharmaceuticals SA
11.9.1 Rhizen Pharmaceuticals SA Company Details
11.9.2 Rhizen Pharmaceuticals SA Business Overview
11.9.3 Rhizen Pharmaceuticals SA Canine Mammary Tumor Treatment Introduction
11.9.4 Rhizen Pharmaceuticals SA Revenue in Canine Mammary Tumor Treatment Business (2016-2021)
11.9.5 Rhizen Pharmaceuticals SA Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Canine Mammary Tumor Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Adenomas
Table 3. Key Players of Carcinomas
Table 4. Key Players of Adenocarcinomas
Table 5. Global Canine Mammary Tumor Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Canine Mammary Tumor Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Canine Mammary Tumor Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Canine Mammary Tumor Treatment Market Share by Regions (2016-2021)
Table 9. Global Canine Mammary Tumor Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Canine Mammary Tumor Treatment Market Share by Regions (2022-2027)
Table 11. Canine Mammary Tumor Treatment Market Trends
Table 12. Canine Mammary Tumor Treatment Market Drivers
Table 13. Canine Mammary Tumor Treatment Market Challenges
Table 14. Canine Mammary Tumor Treatment Market Restraints
Table 15. Global Canine Mammary Tumor Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Canine Mammary Tumor Treatment Market Share by Players (2016-2021)
Table 17. Global Top Canine Mammary Tumor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Canine Mammary Tumor Treatment as of 2020)
Table 18. Ranking of Global Top Canine Mammary Tumor Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Canine Mammary Tumor Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Canine Mammary Tumor Treatment Product Solution and Service
Table 22. Date of Enter into Canine Mammary Tumor Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Canine Mammary Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Canine Mammary Tumor Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Canine Mammary Tumor Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Canine Mammary Tumor Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Canine Mammary Tumor Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Canine Mammary Tumor Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Canine Mammary Tumor Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Canine Mammary Tumor Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Canine Mammary Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Canine Mammary Tumor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Canine Mammary Tumor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Canine Mammary Tumor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Canine Mammary Tumor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Canine Mammary Tumor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Canine Mammary Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Canine Mammary Tumor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Canine Mammary Tumor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Canine Mammary Tumor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Canine Mammary Tumor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Canine Mammary Tumor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Canine Mammary Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Canine Mammary Tumor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Canine Mammary Tumor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Canine Mammary Tumor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Canine Mammary Tumor Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Canine Mammary Tumor Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Canine Mammary Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Canine Mammary Tumor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Canine Mammary Tumor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Canine Mammary Tumor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Canine Mammary Tumor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Canine Mammary Tumor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Canine Mammary Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Canine Mammary Tumor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Canine Mammary Tumor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Canine Mammary Tumor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Canine Mammary Tumor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Canine Mammary Tumor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Oasmia Pharmaceuticals AB Company Details
Table 63. Oasmia Pharmaceuticals AB Business Overview
Table 64. Oasmia Pharmaceuticals AB Canine Mammary Tumor Treatment Product
Table 65. Oasmia Pharmaceuticals AB Revenue in Canine Mammary Tumor Treatment Business (2016-2021) & (US$ Million)
Table 66. Oasmia Pharmaceuticals AB Recent Development
Table 67. Aratana Therapeutics, Inc. Company Details
Table 68. Aratana Therapeutics, Inc. Business Overview
Table 69. Aratana Therapeutics, Inc. Canine Mammary Tumor Treatment Product
Table 70. Aratana Therapeutics, Inc. Revenue in Canine Mammary Tumor Treatment Business (2016-2021) & (US$ Million)
Table 71. Aratana Therapeutics, Inc. Recent Development
Table 72. VetDC, Inc. Company Details
Table 73. VetDC, Inc. Business Overview
Table 74. VetDC, Inc. Canine Mammary Tumor Treatment Product
Table 75. VetDC, Inc. Revenue in Canine Mammary Tumor Treatment Business (2016-2021) & (US$ Million)
Table 76. VetDC, Inc. Recent Development
Table 77. AB Science Company Details
Table 78. AB Science Business Overview
Table 79. AB Science Canine Mammary Tumor Treatment Product
Table 80. AB Science Revenue in Canine Mammary Tumor Treatment Business (2016-2021) & (US$ Million)
Table 81. AB Science Recent Development
Table 82. Boehringer Ingelheim International GmbH Company Details
Table 83. Boehringer Ingelheim International GmbH Business Overview
Table 84. Boehringer Ingelheim International GmbH Canine Mammary Tumor Treatment Product
Table 85. Boehringer Ingelheim International GmbH Revenue in Canine Mammary Tumor Treatment Business (2016-2021) & (US$ Million)
Table 86. Boehringer Ingelheim International GmbH Recent Development
Table 87. Zoetis Company Details
Table 88. Zoetis Business Overview
Table 89. Zoetis Canine Mammary Tumor Treatment Product
Table 90. Zoetis Revenue in Canine Mammary Tumor Treatment Business (2016-2021) & (US$ Million)
Table 91. Zoetis Recent Development
Table 92. VCA Hospitals Company Details
Table 93. VCA Hospitals Business Overview
Table 94. VCA Hospitals Canine Mammary Tumor Treatment Product
Table 95. VCA Hospitals Revenue in Canine Mammary Tumor Treatment Business (2016-2021) & (US$ Million)
Table 96. VCA Hospitals Recent Development
Table 97. Karyopharm Therapeutics, Inc. Company Details
Table 98. Karyopharm Therapeutics, Inc. Business Overview
Table 99. Karyopharm Therapeutics, Inc. Revenue in Canine Mammary Tumor Treatment Business (2016-2021) & (US$ Million)
Table 100. Karyopharm Therapeutics, Inc. Recent Development
Table 101. Rhizen Pharmaceuticals SA Company Details
Table 102. Rhizen Pharmaceuticals SA Business Overview
Table 103. Rhizen Pharmaceuticals SA Canine Mammary Tumor Treatment Product
Table 104. Rhizen Pharmaceuticals SA Revenue in Canine Mammary Tumor Treatment Business (2016-2021) & (US$ Million)
Table 105. Rhizen Pharmaceuticals SA Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Canine Mammary Tumor Treatment Market Share by Type: 2020 VS 2027
Figure 2. Adenomas Features
Figure 3. Carcinomas Features
Figure 4. Adenocarcinomas Features
Figure 5. Global Canine Mammary Tumor Treatment Market Share by Application: 2020 VS 2027
Figure 6. Veterinary Hospitals Case Studies
Figure 7. Veterinary Clinics Case Studies
Figure 8. Others Case Studies
Figure 9. Canine Mammary Tumor Treatment Report Years Considered
Figure 10. Global Canine Mammary Tumor Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Canine Mammary Tumor Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Canine Mammary Tumor Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Canine Mammary Tumor Treatment Market Share by Regions (2022-2027)
Figure 14. Global Canine Mammary Tumor Treatment Market Share by Players in 2020
Figure 15. Global Top Canine Mammary Tumor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Canine Mammary Tumor Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Canine Mammary Tumor Treatment Revenue in 2020
Figure 17. Global Canine Mammary Tumor Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Canine Mammary Tumor Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Canine Mammary Tumor Treatment Market Share by Type (2016-2027)
Figure 21. North America Canine Mammary Tumor Treatment Market Share by Application (2016-2027)
Figure 22. North America Canine Mammary Tumor Treatment Market Share by Country (2016-2027)
Figure 23. United States Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Canine Mammary Tumor Treatment Market Share by Type (2016-2027)
Figure 27. Europe Canine Mammary Tumor Treatment Market Share by Application (2016-2027)
Figure 28. Europe Canine Mammary Tumor Treatment Market Share by Country (2016-2027)
Figure 29. Germany Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Canine Mammary Tumor Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Canine Mammary Tumor Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Canine Mammary Tumor Treatment Market Share by Region (2016-2027)
Figure 39. China Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Canine Mammary Tumor Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Canine Mammary Tumor Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Canine Mammary Tumor Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Canine Mammary Tumor Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Canine Mammary Tumor Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Canine Mammary Tumor Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Canine Mammary Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Oasmia Pharmaceuticals AB Revenue Growth Rate in Canine Mammary Tumor Treatment Business (2016-2021)
Figure 59. Aratana Therapeutics, Inc. Revenue Growth Rate in Canine Mammary Tumor Treatment Business (2016-2021)
Figure 60. VetDC, Inc. Revenue Growth Rate in Canine Mammary Tumor Treatment Business (2016-2021)
Figure 61. AB Science Revenue Growth Rate in Canine Mammary Tumor Treatment Business (2016-2021)
Figure 62. Boehringer Ingelheim International GmbH Revenue Growth Rate in Canine Mammary Tumor Treatment Business (2016-2021)
Figure 63. Zoetis Revenue Growth Rate in Canine Mammary Tumor Treatment Business (2016-2021)
Figure 64. VCA Hospitals Revenue Growth Rate in Canine Mammary Tumor Treatment Business (2016-2021)
Figure 65. Karyopharm Therapeutics, Inc. Revenue Growth Rate in Canine Mammary Tumor Treatment Business (2016-2021)
Figure 66. Rhizen Pharmaceuticals SA Revenue Growth Rate in Canine Mammary Tumor Treatment Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed

---